Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 60687-554

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 60687-554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

18 mg Methylphenidate HCl Er Tablet Blister (18 mg Blister)

18 mg Methylphenidate HCl Er Tablet Blister (18 mg Blister)
Labels for Methylphenidate Hydrochloride Extended-Release Tablets, USP, 18 mg strength, by American Health Packaging. Each label includes the drug name, strength, dosage form (extended-release tablet), a barcode, and space for expiration and lot numbers. Multiple identical labels are displayed on one sheet.*
FDA Label Image

18 mg Methylphenidate HCl Er Tablets Carton (18 mg Carton)

18 mg Methylphenidate HCl Er Tablets Carton (18 mg Carton)
Methylphenidate Hydrochloride Extended-Release Tablets, USP 18 mg oral tablets packaging label. The label states the quantity as 30 tablets (3 x 10) and includes NDC 60687-532-21. Labeler is American Health Packaging. The label includes dosing instructions and storage advice, specifying controlled-release formulation and temperature guidelines, along with a warning to keep out of reach of children.*
FDA Label Image

27 mg Methylphenidate HCl Er Tablet Blilster (27 mg Blister)

27 mg Methylphenidate HCl Er Tablet Blilster (27 mg Blister)
Label for Methylphenidate Hydrochloride extended-release tablets, USP, 27 mg strength. The label includes the NDC barcode and the manufacturer, American Health Packaging, Columbus, Ohio. Expiry and lot information fields are present but not filled in. This label is repeated multiple times on the image.*
FDA Label Image

27 mg Methylphenidate HCl Er Tablets Carton (27 mg Carton)

27 mg Methylphenidate HCl Er Tablets Carton (27 mg Carton)
Label for Methylphenidate Hydrochloride extended-release tablets, 27 mg strength, oral dosage form. The label indicates 30 tablets per package in three blister packs of 10 each. It is a prescription drug by American Health Packaging, Columbus, Ohio. Additional instructions include pharmacist and patient guidance about dosage and storage.*
FDA Label Image

27 mg Methylphenidate HCl Er Tablet Blister (36 mg Blister)

27 mg Methylphenidate HCl Er Tablet Blister (36 mg Blister)
Packaging labels for Methylphenidate Hydrochloride Extended-Release Tablets, USP 36 mg, distributed by American Health Packaging, Columbus, Ohio. Each label includes the proprietary name, dosage form as extended-release tablet, dosage strength of 36 mg, a barcode, and space for lot number and expiration date.*
FDA Label Image

36 mg Methylphenidate HCl Er Tablets Carton (36 mg Carton)

36 mg Methylphenidate HCl Er Tablets Carton (36 mg Carton)
Methylphenidate Hydrochloride Extended-Release Tablets, USP 36 mg, in a package of 30 tablets (3 x 10) by American Health Packaging. Label includes NDC 60687-554-21, indicates Rx only, and provides pharmacist and patient instructions regarding dosage, storage, and drug protection.*
FDA Label Image

54 mg Methylphenidate HCl Er Tablet Blister (54 mg Blister)

54 mg Methylphenidate HCl Er Tablet Blister (54 mg Blister)
Multiple identical labels for Methylphenidate Hydrochloride Extended-Release Tablets, USP 54 mg, each label showing the product name, strength, dosage form, a barcode with NDC code, lot number, expiration date placeholder, and manufactured by American Health Packaging, Columbus, Ohio.*
FDA Label Image

45 mg Methylphenidate HCl Er Tablets Carton (54 mg Carton)

45 mg Methylphenidate HCl Er Tablets Carton (54 mg Carton)
Label for Methylphenidate Hydrochloride Extended-Release Tablets, USP 54 mg, oral dosage form. The label shows a package of 30 tablets (3 blister packs of 10), with prescription-only status. It is labeled by American Health Packaging and includes barcodes, usage instructions, and storage information.*
FDA Label Image

Ahp53221

Ahp53221
Tablet extended release form of Methylphenidate Hydrochloride in a yellow oblong shape with imprint code '212' on one side. The image shows both the imprinted and plain sides of the tablet. It is an oral dosage form from American Health Packaging.*
FDA Label Image

Ahp54321

Ahp54321
Methylphenidate Hydrochloride extended-release tablet imprinted with '213' on one side. The tablet is oval, peach-colored, and unscored. This oral dosage form is part of the American Health Packaging line, available in strengths including 18 mg, 27 mg, 36 mg, and 54 mg.*
FDA Label Image

Ahp55421

Ahp55421
Methylphenidate Hydrochloride extended-release oral tablets. The image shows two white capsule-shaped tablets, one imprinted with the code '214' and the other without visible markings. These tablets are available in various strengths including 18 mg, 27 mg, 36 mg, and 54 mg, and are labeled by American Health Packaging.*
FDA Label Image

Ahp56521

Ahp56521
Methylphenidate Hydrochloride extended-release oral tablet in a light brown color, imprinted with '215' on one side. The image shows both the imprinted and plain sides of the capsule-shaped tablet, consistent with strengths available from American Health Packaging.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A line graph showing mean plasma methylphenidate concentration (ng/mL) over time (hours) for extended-release 18 mg tablets taken once daily versus 5 mg tablets taken three times daily. The x-axis represents time up to 32 hours, and the y-axis shows concentration up to 5 ng/mL, with concentration curves for both dosing regimens.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A bar graph comparing maximum symptoms on the Inattention/Overactivity Scale between Methylphenidate Hydrochloride extended-release tablets taken once daily and placebo groups across three studies, including Study 3 at Week 4. The y-axis ranges from no symptoms to a maximum score of 15, with symptom scores consistently lower for the Methylphenidate group in all studies.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A line graph comparing the combined attention subscale scores over 12 hours post initial dose between methylphenidate hydrochloride extended-release tablets taken once daily and placebo. The y-axis represents attention levels from more attentive to less attentive, and the x-axis shows hours post initial dose. Data points show mean scores with standard error.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Methylphenidate Hydrochloride, showing the molecular arrangement of its atoms including a phenyl ring, ester group, and piperidine ring with hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.